International Health Policy Conference
June 15, 2016Treatment for non-Hodgkin lymphoma has been available in SUS since 2013
June 23, 2016Document explains the decision and regulatory process that leads to the adoption of new techniques in health networks. For publishing specialists, developing countries such as Brazil, we must take care to ensure that investments in technology do not diminish the resources spent on medical care.
Innovations in health must pass not only by the endorsement of regulatory agencies, but also by analysis that reflects the risks, effectiveness and custo-benefit relationship of its large-scale application in care systems.
The Pan-American Health Organization (OPAS) in Brazil released, last week (3), a publication that discusses the risks, benefits and costs of incorporation of new technologies in health systems. The document is the eighth fascicle of the series “Rational Use of Medications: foundation in therapeutic conduct and the macroprocesses of Farmacêutic Assistance”.
The new chapter of the series warns that, in public health networks, new technologies can only be used after receiving authorization from regulatory agencies.
Not Brazil, the body responsible for registering techniques is not yet approved by the National Health Surveillance Agency (ANVISA), but the regulation of the organization is not sufficient to guarantee the incorporation of new treatment and diagnostic tools.
Ter a innovação como padrão de consumpción en saúde becomes a meaça à sustainabilitye e ao desenvolvimento two health systems are still incipient two countries in development.
For innovation to be offered in the Single Health System (SUS), it is necessary to evaluate its effectiveness, security and cost-effectiveness relationship, as well as its organizational and logistical impact.
“To have innovation as a pattern of consumption in health becomes an issue of sustainability and development of two health systems that are still incipient in two developing countries,” explains the author of the issue and the director of the Department of Management and Incorporation of Technologies in the Health Ministry. da Saúde, Clarice Alegre Petramale.
“A substitution of care for technology, once there will not be enough resources to maintain both investments, is a bet in the future. “The seduction of technology as a reality, apart from not plotting results for health, will also deepen the disorganization of two public health systems.”
Second to publication, health systems must develop articulation strategies between municipalities and regions, in order to establish references for the technological procedures selected as essential to medical care.
“Technical competence, communication and transparency are essential attributes for the technology endorsement process, given that this process is of interest to all users of the public and private health system, as health institutions, justice and the Brazilian Congress,” completes specialist.
The new fascicle of OPAS — entitled “Avaliação e incorporação: do we really need?” — may be accessed here. (Source: ONUBR website)